Long non-coding RNA HOXA11-AS in human cancer: A meta-analysis

This meta-analysis showed that increased expression of HOXA11-AS is a risk factor for poor clinical outcomes in numerous tumors and may act as a novel biomarker for poor prognosis and metastasis in cancers.